ALS Limited announces solid FY24 results amid market challenges, introduces new growth framework

20 MAY 2024
READ MORE

Recent stories

conceptual image of financials and graphs 

Featured stories

New US FDA MoCRA budget targets PFAS in cosmetics

  READ MORE

New PFAS regulations are coming: what you need to know

  READ MORE

ALS strategically expands and strengthens its European and USA Life Sciences presence

  READ MORE

Other stories